Furthermore, these chemotherapy drugs-derived nanoparticles encapsulating p53 mRNA displayed significant antitumor efficacy in the mouse models of orthotopic triple-negative breast cancer xenografts. This evidence concerns the gene TP53 and triple-negative breast carcinoma.